25 XP   0   0   10

Harmony Biosciences Holdings
Buy, Hold or Sell?

Let's analyse Harmony Biosciences Holdings together

PenkeI guess you are interested in Harmony Biosciences Holdings. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Harmony Biosciences Holdings. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Harmony Biosciences Holdings

I send you an email if I find something interesting about Harmony Biosciences Holdings.

Quick analysis of Harmony Biosciences Holdings (30 sec.)










What can you expect buying and holding a share of Harmony Biosciences Holdings? (30 sec.)

How much money do you get?

How much money do you get?
$1.85
When do you have the money?
1 year
How often do you get paid?
23.5%

What is your share worth?

Current worth
$7.93
Expected worth in 1 year
$9.33
How sure are you?
88.2%

+ What do you gain per year?

Total Gains per Share
$3.25
Return On Investment
11.2%

For what price can you sell your share?

Current Price per Share
$28.93
Expected price per share
$22.89 - $34.08
How sure are you?
50%

1. Valuation of Harmony Biosciences Holdings (5 min.)




Live pricePrice per Share (EOD)

$28.93

Intrinsic Value Per Share

$73.11 - $86.98

Total Value Per Share

$81.05 - $94.91

2. Growth of Harmony Biosciences Holdings (5 min.)




Is Harmony Biosciences Holdings growing?

Current yearPrevious yearGrowGrow %
How rich?$466.9m$301.9m$167.1m35.6%

How much money is Harmony Biosciences Holdings making?

Current yearPrevious yearGrowGrow %
Making money$32.2m$45.3m-$13.1m-40.8%
Net Profit Margin22.5%40.0%--

How much money comes from the company's main activities?

3. Financial Health of Harmony Biosciences Holdings (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#119 / 1010

Most Revenue
#85 / 1010

Most Profit
#66 / 1010

Most Efficient
#72 / 1010

What can you expect buying and holding a share of Harmony Biosciences Holdings? (5 min.)

Welcome investor! Harmony Biosciences Holdings's management wants to use your money to grow the business. In return you get a share of Harmony Biosciences Holdings.

What can you expect buying and holding a share of Harmony Biosciences Holdings?

First you should know what it really means to hold a share of Harmony Biosciences Holdings. And how you can make/lose money.

Speculation

The Price per Share of Harmony Biosciences Holdings is $28.93. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Harmony Biosciences Holdings.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Harmony Biosciences Holdings, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $7.93. Based on the TTM, the Book Value Change Per Share is $0.35 per quarter. Based on the YOY, the Book Value Change Per Share is $0.86 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.46 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Harmony Biosciences Holdings.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.451.6%0.531.8%0.742.6%0.240.8%0.240.8%
Usd Book Value Change Per Share0.000.0%0.351.2%0.863.0%0.471.6%0.471.6%
Usd Dividend Per Share0.943.2%0.461.6%0.000.0%0.160.5%0.160.5%
Usd Total Gains Per Share0.943.3%0.812.8%0.863.0%0.622.1%0.622.1%
Usd Price Per Share32.30-33.23-49.20-31.88-31.88-
Price to Earnings Ratio17.86-15.83-22.77--139.34--139.34-
Price-to-Total Gains Ratio34.30-41.53-73.26-74.19-74.19-
Price to Book Ratio4.07-4.28-10.53-9.42-9.42-
Price-to-Total Gains Ratio34.30-41.53-73.26-74.19-74.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share28.93
Number of shares34
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.460.16
Usd Book Value Change Per Share0.350.47
Usd Total Gains Per Share0.810.62
Gains per Quarter (34 shares)27.6021.15
Gains per Year (34 shares)110.4084.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16348100216375
21269521042127160
318914332063190245
425219043084254330
5314238540106317415
6377285650127381500
7440333760148444585
8503380870169508670
9566428980190571755
106294751090211635840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%11.06.00.064.7%11.06.00.064.7%11.06.00.064.7%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%14.03.00.082.4%14.03.00.082.4%14.03.00.082.4%
Dividend per Share3.00.01.075.0%3.00.09.025.0%4.00.013.023.5%4.00.013.023.5%4.00.013.023.5%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%15.02.00.088.2%15.02.00.088.2%15.02.00.088.2%

Fundamentals of Harmony Biosciences Holdings

About Harmony Biosciences Holdings

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Fundamental data was last updated by Penke on 2024-04-11 10:57:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Harmony Biosciences Holdings.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Harmony Biosciences Holdings earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Harmony Biosciences Holdings to the Biotechnology industry mean.
  • A Net Profit Margin of 15.8% means that $0.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harmony Biosciences Holdings:

  • The MRQ is 15.8%. The company is making a huge profit. +2
  • The TTM is 22.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.8%TTM22.5%-6.7%
TTM22.5%YOY40.0%-17.5%
TTM22.5%5Y-29.7%+52.2%
5Y-29.7%10Y-29.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.8%-207.2%+223.0%
TTM22.5%-216.8%+239.3%
YOY40.0%-282.3%+322.3%
5Y-29.7%-436.8%+407.1%
10Y-29.7%-597.3%+567.6%
1.1.2. Return on Assets

Shows how efficient Harmony Biosciences Holdings is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Harmony Biosciences Holdings to the Biotechnology industry mean.
  • 3.3% Return on Assets means that Harmony Biosciences Holdings generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harmony Biosciences Holdings:

  • The MRQ is 3.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.3%TTM4.2%-0.9%
TTM4.2%YOY7.5%-3.3%
TTM4.2%5Y-0.1%+4.3%
5Y-0.1%10Y-0.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3%-13.3%+16.6%
TTM4.2%-12.8%+17.0%
YOY7.5%-11.6%+19.1%
5Y-0.1%-13.8%+13.7%
10Y-0.1%-15.6%+15.5%
1.1.3. Return on Equity

Shows how efficient Harmony Biosciences Holdings is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Harmony Biosciences Holdings to the Biotechnology industry mean.
  • 5.7% Return on Equity means Harmony Biosciences Holdings generated $0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harmony Biosciences Holdings:

  • The MRQ is 5.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.7%TTM6.9%-1.2%
TTM6.9%YOY14.3%-7.4%
TTM6.9%5Y6.5%+0.4%
5Y6.5%10Y6.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7%-16.9%+22.6%
TTM6.9%-16.1%+23.0%
YOY14.3%-14.9%+29.2%
5Y6.5%-19.3%+25.8%
10Y6.5%-20.1%+26.6%

1.2. Operating Efficiency of Harmony Biosciences Holdings.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Harmony Biosciences Holdings is operating .

  • Measures how much profit Harmony Biosciences Holdings makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Harmony Biosciences Holdings to the Biotechnology industry mean.
  • An Operating Margin of 32.7% means the company generated $0.33  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harmony Biosciences Holdings:

  • The MRQ is 32.7%. The company is operating very efficient. +2
  • The TTM is 35.5%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ32.7%TTM35.5%-2.7%
TTM35.5%YOY27.6%+7.8%
TTM35.5%5Y-3.5%+38.9%
5Y-3.5%10Y-3.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ32.7%-298.0%+330.7%
TTM35.5%-238.5%+274.0%
YOY27.6%-288.4%+316.0%
5Y-3.5%-486.2%+482.7%
10Y-3.5%-628.4%+624.9%
1.2.2. Operating Ratio

Measures how efficient Harmony Biosciences Holdings is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.76 means that the operating costs are $0.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Harmony Biosciences Holdings:

  • The MRQ is 0.761. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.668. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.761TTM0.668+0.094
TTM0.668YOY0.724-0.056
TTM0.6685Y1.116-0.449
5Y1.11610Y1.1160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7613.235-2.474
TTM0.6683.310-2.642
YOY0.7243.838-3.114
5Y1.1165.679-4.563
10Y1.1167.823-6.707

1.3. Liquidity of Harmony Biosciences Holdings.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Harmony Biosciences Holdings is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.75 means the company has $2.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Harmony Biosciences Holdings:

  • The MRQ is 2.754. The company is able to pay all its short-term debts. +1
  • The TTM is 4.167. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.754TTM4.167-1.413
TTM4.167YOY4.625-0.458
TTM4.1675Y4.588-0.421
5Y4.58810Y4.5880.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7543.863-1.109
TTM4.1674.169-0.002
YOY4.6255.337-0.712
5Y4.5886.122-1.534
10Y4.5886.434-1.846
1.3.2. Quick Ratio

Measures if Harmony Biosciences Holdings is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Harmony Biosciences Holdings to the Biotechnology industry mean.
  • A Quick Ratio of 2.87 means the company can pay off $2.87 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harmony Biosciences Holdings:

  • The MRQ is 2.866. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.430. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.866TTM4.430-1.564
TTM4.430YOY4.786-0.356
TTM4.4305Y4.522-0.092
5Y4.52210Y4.5220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8663.504-0.638
TTM4.4303.991+0.439
YOY4.7865.371-0.585
5Y4.5226.088-1.566
10Y4.5226.395-1.873

1.4. Solvency of Harmony Biosciences Holdings.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Harmony Biosciences Holdings assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Harmony Biosciences Holdings to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.42 means that Harmony Biosciences Holdings assets are financed with 42.4% credit (debt) and the remaining percentage (100% - 42.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harmony Biosciences Holdings:

  • The MRQ is 0.424. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.387. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.424TTM0.387+0.038
TTM0.387YOY0.479-0.092
TTM0.3875Y0.656-0.269
5Y0.65610Y0.6560.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4240.339+0.085
TTM0.3870.337+0.050
YOY0.4790.271+0.208
5Y0.6560.368+0.288
10Y0.6560.388+0.268
1.4.2. Debt to Equity Ratio

Measures if Harmony Biosciences Holdings is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Harmony Biosciences Holdings to the Biotechnology industry mean.
  • A Debt to Equity ratio of 73.8% means that company has $0.74 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harmony Biosciences Holdings:

  • The MRQ is 0.738. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.634. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.738TTM0.634+0.104
TTM0.634YOY0.939-0.305
TTM0.6345Y1.114-0.480
5Y1.11410Y1.1140.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7380.392+0.346
TTM0.6340.403+0.231
YOY0.9390.335+0.604
5Y1.1140.427+0.687
10Y1.1140.461+0.653

2. Market Valuation of Harmony Biosciences Holdings

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Harmony Biosciences Holdings generates.

  • Above 15 is considered overpriced but always compare Harmony Biosciences Holdings to the Biotechnology industry mean.
  • A PE ratio of 17.86 means the investor is paying $17.86 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harmony Biosciences Holdings:

  • The EOD is 15.998. Based on the earnings, the company is fair priced.
  • The MRQ is 17.861. Based on the earnings, the company is fair priced.
  • The TTM is 15.829. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD15.998MRQ17.861-1.864
MRQ17.861TTM15.829+2.033
TTM15.829YOY22.767-6.938
TTM15.8295Y-139.341+155.170
5Y-139.34110Y-139.3410.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD15.998-2.300+18.298
MRQ17.861-2.656+20.517
TTM15.829-2.718+18.547
YOY22.767-4.145+26.912
5Y-139.341-6.258-133.083
10Y-139.341-6.315-133.026
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Harmony Biosciences Holdings:

  • The EOD is 5.560. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.208. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 10.082. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.560MRQ6.208-0.648
MRQ6.208TTM10.082-3.874
TTM10.082YOY-4.698+14.780
TTM10.0825Y10.609-0.527
5Y10.60910Y10.6090.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.560-2.974+8.534
MRQ6.208-3.306+9.514
TTM10.082-3.508+13.590
YOY-4.698-5.613+0.915
5Y10.609-8.378+18.987
10Y10.609-8.873+19.482
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Harmony Biosciences Holdings is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.07 means the investor is paying $4.07 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Harmony Biosciences Holdings:

  • The EOD is 3.646. Based on the equity, the company is fair priced.
  • The MRQ is 4.071. Based on the equity, the company is fair priced.
  • The TTM is 4.280. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.646MRQ4.071-0.425
MRQ4.071TTM4.280-0.209
TTM4.280YOY10.526-6.246
TTM4.2805Y9.421-5.142
5Y9.42110Y9.4210.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.6461.914+1.732
MRQ4.0712.116+1.955
TTM4.2802.097+2.183
YOY10.5262.881+7.645
5Y9.4213.550+5.871
10Y9.4213.936+5.485
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Harmony Biosciences Holdings.

3.1. Institutions holding Harmony Biosciences Holdings

Institutions are holding 90.023% of the shares of Harmony Biosciences Holdings.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Valor Management LLC19.760899.55431121803300
2023-12-31BlackRock Inc10.5750.00496003327-129160-2.1062
2023-12-31FMR Inc9.29520.01315276825-173384-3.1812
2023-12-31Vanguard Group Inc6.47320.00263674764-9388-0.2548
2023-12-31Vivo Capital, LLC4.5916.8926260624700
2023-12-31State Street Corporation2.39650.0021136044713298610.8342
2023-12-31Pacer Advisors, INC.2.15770.11212249101224681534795.1965
2023-12-31Morgan Stanley - Brokerage Accounts1.91340.0031108621533077043.7848
2023-12-31venBio Partners LLC1.82395.0125103539600
2023-12-31Camber Capital Management LLC1.32110.61747500007500000
2023-12-31Geode Capital Management, LLC1.30160.0025738905195292.7147
2023-12-31Dimensional Fund Advisors, Inc.1.2970.007736268-48176-6.1414
2023-12-31Macquarie Group Ltd1.01380.0215575552-376841-39.5678
2023-12-31Goldman Sachs Group Inc0.95510.0016542200340242168.4717
2023-12-31abrdn PLC0.93920.0373533189-48455-8.3307
2023-12-31Federated Hermes Inc0.92540.04215253375018092132.8162
2023-12-31Massachusetts Financial Services Company0.8960.00535086324340.0854
2023-12-31Nuveen Asset Management, LLC0.70940.0042402692-83299-17.14
2023-12-31Northern Trust Corp0.5840.0019331516-12795-3.7161
2023-12-31683 Capital Management LLC0.57250.8598325000-25000-7.1429
Total 69.5018113.197839455455+2393953+6.1%

3.2. Funds holding Harmony Biosciences Holdings

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28Pacer US Small Cap Cash Cows 100 ETF4.39270.8608249371688200.3549
2024-02-29Fidelity Growth Compy Commingled Pl O4.13530.0961234759100
2024-03-28iShares Core S&P Small-Cap ETF3.92290.0931222699931680.1425
2023-12-31HBM Healthcare Investments AG Ord3.78363.4749214794300
2024-02-29Fidelity Growth Company Fund3.08880.0943175347500
2024-02-29Vanguard Total Stock Mkt Idx Inv1.78180.00211011491-19200-1.8628
2024-02-29Vanguard Small Cap Index1.46280.01983041577240.9389
2024-03-28iShares Russell 2000 ETF1.3910.04057896643810.0483
2024-02-29Fidelity Growth Company K60.97860.09755557000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.86960.01554936773270.0663
2024-02-29Vanguard Small Cap Growth Index Inv0.8210.042946604977401.6888
2024-02-29Fidelity Series Growth Company0.6710.0774380923-9139-2.343
2023-12-31Delaware Ivy Small Cap Growth C0.66980.892638023100
2024-03-29Avantis US Small Cap Value ETF0.59610.104833841400
2024-02-29MFS New Discovery I0.58750.434933352700
2024-01-31Fidelity Small Cap Index0.57710.041732762052101.616
2023-12-31Federated Hermes MDT Small Cap Core IS0.54720.85013106353106350
2023-12-31Federated Hermes MDT SCC Institutional0.54720.8483106353106350
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.51920.09412947193000.1019
2024-03-28iShares Russell 2000 Growth ETF0.49160.0804279069-324-0.116
Total 31.83488.260218072363+626277+3.5%

3.3. Insider Transactions

Insiders are holding 19.375% of the shares of Harmony Biosciences Holdings.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-15Jeffrey DierksSELL1197932
2024-03-08Jeffrey DierksSELL19432

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Harmony Biosciences Holdings compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0030.349-99%0.861-100%0.467-99%0.467-99%
Book Value Per Share--7.9357.773+2%4.936+61%3.651+117%3.651+117%
Current Ratio--2.7544.167-34%4.625-40%4.588-40%4.588-40%
Debt To Asset Ratio--0.4240.387+10%0.479-11%0.656-35%0.656-35%
Debt To Equity Ratio--0.7380.634+16%0.939-21%1.114-34%1.114-34%
Dividend Per Share--0.9390.462+103%-+100%0.155+505%0.155+505%
Eps--0.4520.533-15%0.741-39%0.242+87%0.242+87%
Free Cash Flow Per Share--1.3010.911+43%0.588+121%0.338+285%0.338+285%
Free Cash Flow To Equity Per Share--0.3910.469-17%0.616-36%0.490-20%0.490-20%
Gross Profit Margin---0.0100.225-105%0.414-103%32.309-100%32.309-100%
Intrinsic Value_10Y_max--86.979--------
Intrinsic Value_10Y_min--73.115--------
Intrinsic Value_1Y_max--3.440--------
Intrinsic Value_1Y_min--3.376--------
Intrinsic Value_3Y_max--14.357--------
Intrinsic Value_3Y_min--13.625--------
Intrinsic Value_5Y_max--30.121--------
Intrinsic Value_5Y_min--27.612--------
Market Cap1642330063.000-16%1900961331.6002006490473.585-5%3006234281.160-37%1906660312.0260%1906660312.0260%
Net Profit Margin--0.1580.225-30%0.400-61%-0.297+288%-0.297+288%
Operating Margin--0.3270.355-8%0.276+18%-0.035+111%-0.035+111%
Operating Ratio--0.7610.668+14%0.724+5%1.116-32%1.116-32%
Pb Ratio3.646-12%4.0714.280-5%10.526-61%9.421-57%9.421-57%
Pe Ratio15.998-12%17.86115.829+13%22.767-22%-139.341+880%-139.341+880%
Price Per Share28.930-12%32.30033.228-3%49.203-34%31.883+1%31.883+1%
Price To Free Cash Flow Ratio5.560-12%6.20810.082-38%-4.698+176%10.609-41%10.609-41%
Price To Total Gains Ratio30.721-12%34.29941.534-17%73.256-53%74.194-54%74.194-54%
Quick Ratio--2.8664.430-35%4.786-40%4.522-37%4.522-37%
Return On Assets--0.0330.042-22%0.075-57%-0.001+102%-0.001+102%
Return On Equity--0.0570.069-17%0.143-60%0.065-12%0.065-12%
Total Gains Per Share--0.9420.812+16%0.861+9%0.622+51%0.622+51%
Usd Book Value--466992000.000469134250.0000%301939500.000+55%219903294.118+112%219903294.118+112%
Usd Book Value Change Per Share--0.0030.349-99%0.861-100%0.467-99%0.467-99%
Usd Book Value Per Share--7.9357.773+2%4.936+61%3.651+117%3.651+117%
Usd Dividend Per Share--0.9390.462+103%-+100%0.155+505%0.155+505%
Usd Eps--0.4520.533-15%0.741-39%0.242+87%0.242+87%
Usd Free Cash Flow--76558000.00054768750.000+40%36116500.000+112%20946352.941+265%20946352.941+265%
Usd Free Cash Flow Per Share--1.3010.911+43%0.588+121%0.338+285%0.338+285%
Usd Free Cash Flow To Equity Per Share--0.3910.469-17%0.616-36%0.490-20%0.490-20%
Usd Market Cap1642330063.000-16%1900961331.6002006490473.585-5%3006234281.160-37%1906660312.0260%1906660312.0260%
Usd Price Per Share28.930-12%32.30033.228-3%49.203-34%31.883+1%31.883+1%
Usd Profit--26607000.00032213250.000-17%45367000.000-41%15972588.235+67%15972588.235+67%
Usd Revenue--168412000.000145505500.000+16%109463750.000+54%87709058.824+92%87709058.824+92%
Usd Total Gains Per Share--0.9420.812+16%0.861+9%0.622+51%0.622+51%
 EOD+4 -4MRQTTM+13 -23YOY+17 -195Y+23 -1310Y+23 -13

4.2. Fundamental Score

Let's check the fundamental score of Harmony Biosciences Holdings based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.998
Price to Book Ratio (EOD)Between0-13.646
Net Profit Margin (MRQ)Greater than00.158
Operating Margin (MRQ)Greater than00.327
Quick Ratio (MRQ)Greater than12.866
Current Ratio (MRQ)Greater than12.754
Debt to Asset Ratio (MRQ)Less than10.424
Debt to Equity Ratio (MRQ)Less than10.738
Return on Equity (MRQ)Greater than0.150.057
Return on Assets (MRQ)Greater than0.050.033
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Harmony Biosciences Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.435
Ma 20Greater thanMa 5030.349
Ma 50Greater thanMa 10031.492
Ma 100Greater thanMa 20031.771
OpenGreater thanClose28.880
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -151120-31-491-5226-5165182
Total Other Income Expense Net -3,510867-2,6432,612-31-9,740-9,7719,964193



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets811,448
Total Liabilities344,456
Total Stockholder Equity466,992
 As reported
Total Liabilities 344,456
Total Stockholder Equity+ 466,992
Total Assets = 811,448

Assets

Total Assets811,448
Total Current Assets451,070
Long-term Assets360,378
Total Current Assets
Cash And Cash Equivalents 311,660
Short-term Investments 41,800
Net Receivables 74,140
Inventory 5,363
Other Current Assets 5,537
Total Current Assets  (as reported)451,070
Total Current Assets  (calculated)438,500
+/- 12,570
Long-term Assets
Property Plant Equipment 371
Long Term Investments 72,169
Intangible Assets 137,108
Long-term Assets Other 6,568
Long-term Assets  (as reported)360,378
Long-term Assets  (calculated)216,216
+/- 144,162

Liabilities & Shareholders' Equity

Total Current Liabilities163,781
Long-term Liabilities180,675
Total Stockholder Equity466,992
Total Current Liabilities
Short-term Debt 15,000
Short Long Term Debt 15,000
Accounts payable 17,730
Other Current Liabilities 7,810
Total Current Liabilities  (as reported)163,781
Total Current Liabilities  (calculated)55,540
+/- 108,241
Long-term Liabilities
Long term Debt 178,566
Long-term Liabilities Other 2,109
Long-term Liabilities  (as reported)180,675
Long-term Liabilities  (calculated)180,675
+/-0
Total Stockholder Equity
Common Stock1
Retained Earnings -143,277
Accumulated Other Comprehensive Income 2
Other Stockholders Equity 610,266
Total Stockholder Equity (as reported)466,992
Total Stockholder Equity (calculated)466,992
+/-0
Other
Capital Stock1
Cash and Short Term Investments 353,460
Common Stock Shares Outstanding 58,853
Current Deferred Revenue123,241
Liabilities and Stockholders Equity 811,448
Net Debt -118,094
Net Invested Capital 660,558
Net Working Capital 287,289
Short Long Term Debt Total 193,566



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
106,703
163,094
168,819
320,073
427,074
337,252
359,695
391,092
433,443
464,005
505,034
643,464
673,870
715,092
760,183
777,766
811,448
811,448777,766760,183715,092673,870643,464505,034464,005433,443391,092359,695337,252427,074320,073168,819163,094106,703000
   > Total Current Assets 
0
0
31,497
31,497
90,502
98,287
250,242
262,891
177,744
204,714
240,691
284,439
280,257
322,702
382,082
400,285
418,087
455,641
462,998
451,070
451,070462,998455,641418,087400,285382,082322,702280,257284,439240,691204,714177,744262,891250,24298,28790,50231,49731,49700
       Cash And Cash Equivalents 
0
0
0
24,457
71,517
76,280
221,740
228,631
141,169
159,686
189,704
234,309
224,499
236,533
261,343
243,784
287,962
317,415
324,603
311,660
311,660324,603317,415287,962243,784261,343236,533224,499234,309189,704159,686141,169228,631221,74076,28071,51724,457000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
17,638
46,420
79,331
55,916
53,568
46,071
41,800
41,80046,07153,56855,91679,33146,42017,6380000000000000
       Net Receivables 
0
0
4,255
4,255
11,308
15,239
16,326
22,176
23,615
31,196
33,206
34,843
38,133
49,822
55,065
54,740
52,575
63,812
67,264
74,140
74,14067,26463,81252,57554,74055,06549,82238,13334,84333,20631,19623,61522,17616,32615,23911,3084,2554,25500
       Other Current Assets 
0
0
261
261
168
16
5,625
1,302
1,466
1,559
3,183
3,218
3,410
3,674
4,108
8,786
6,145
6,550
5,704
5,537
5,5375,7046,5506,1458,7864,1083,6743,4103,2183,1831,5591,4661,3025,6251616826126100
   > Long-term Assets 
0
0
0
75,206
72,592
70,532
69,831
164,183
159,508
154,981
150,401
149,004
183,748
182,332
261,382
273,585
297,005
304,542
314,768
360,378
360,378314,768304,542297,005273,585261,382182,332183,748149,004150,401154,981159,508164,18369,83170,53272,59275,206000
       Property Plant Equipment 
0
0
1,330
1,330
1,233
1,138
1,038
938
842
944
937
820
748
695
680
573
470
572
428
371
3714285724705736806957488209379448429381,0381,1381,2331,3301,33000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,747
8,280
22,568
48,538
58,651
67,700
72,169
72,16967,70058,65148,53822,5688,2804,7470000000000000
       Intangible Assets 
0
0
0
72,185
70,400
68,492
66,625
162,343
157,764
153,135
148,562
143,919
178,837
172,876
166,914
160,953
154,992
149,031
143,069
137,108
137,108143,069149,031154,992160,953166,914172,876178,837143,919148,562153,135157,764162,34366,62568,49270,40072,185000
       Other Assets 
0
0
1,691
1,691
959
902
2,168
902
902
902
902
4,265
1,029
1,029
82,850
87,179
90,621
96,288
0
0
0096,28890,62187,17982,8501,0291,0294,2659029029029022,1689029591,6911,69100
> Total Liabilities 
0
0
0
118,288
212,781
218,170
225,524
329,894
229,373
233,144
239,074
246,936
249,502
258,501
299,580
271,032
272,051
275,011
296,434
344,456
344,456296,434275,011272,051271,032299,580258,501249,502246,936239,074233,144229,373329,894225,524218,170212,781118,288000
   > Total Current Liabilities 
0
0
19,892
19,892
16,454
21,061
31,790
134,539
33,437
36,595
47,623
53,775
56,528
65,764
107,357
78,884
85,363
93,045
112,408
163,781
163,781112,40893,04585,36378,884107,35765,76456,52853,77547,62336,59533,437134,53931,79021,06116,45419,89219,89200
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
2,000
2,000
2,000
2,000
2,000
2,000
6,500
11,000
15,000
15,000
15,00015,00011,0006,5002,0002,0002,0002,0002,0002,0000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
2,000
2,000
2,000
2,000
2,000
2,000
6,500
11,000
15,000
15,000
15,00015,00011,0006,5002,0002,0002,0002,0002,0002,0000000000000
       Accounts payable 
0
0
6,360
6,360
4,851
2,073
9,347
2,556
4,391
2,006
4,179
1,001
6,904
6,661
10,049
3,786
6,414
6,563
6,539
17,730
17,7306,5396,5636,4143,78610,0496,6616,9041,0014,1792,0064,3912,5569,3472,0734,8516,3606,36000
       Other Current Liabilities 
0
0
753
13,532
11,603
18,988
22,443
131,983
29,046
34,589
436
1,360
47,624
57,103
95,308
73,098
72,449
3,947
7,786
7,810
7,8107,7863,94772,44973,09895,30857,10347,6241,36043634,58929,046131,98322,44318,98811,60313,53275300
   > Long-term Liabilities 
0
0
0
98,396
196,327
197,109
193,734
195,355
195,936
196,549
191,451
193,161
192,974
192,737
192,223
192,148
186,688
181,966
184,026
180,675
180,675184,026181,966186,688192,148192,223192,737192,974193,161191,451196,549195,936195,355193,734197,109196,32798,396000
       Long term Debt Total 
0
0
0
0
0
0
0
194,250
194,913
195,610
190,069
189,984
189,896
189,807
189,725
189,647
185,063
180,487
0
0
00180,487185,063189,647189,725189,807189,896189,984190,069195,610194,913194,2500000000
       Other Liabilities 
0
0
450
450
645
648
876
1,105
1,023
939
1,382
3,177
1,060
1,182
887
1,526
884
0
0
0
0008841,5268871,1821,0603,1771,3829391,0231,10587664864545045000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
212
192
0
0
0
0
0
0
0
0
0
0
0
000000000001922120000000
> Total Stockholder Equity
0
0
0
-11,585
-49,687
-49,351
94,549
97,180
107,879
126,551
152,018
186,507
214,503
246,533
343,884
402,838
443,041
485,172
481,332
466,992
466,992481,332485,172443,041402,838343,884246,533214,503186,507152,018126,551107,87997,18094,549-49,351-49,687-11,585000
   Common Stock
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
11111111111111110000
   Retained Earnings Total Equity00-208,345-242,645-272,130-320,639-408,582-432,113-453,598-476,312-466,692-480,809-488,1950000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-320,073
0
0
0
0
0
0
-29
-178
-151
-31
-522
-516
2
2-516-522-31-151-178-29000000-320,073000000
   Capital Surplus 
0
0
0
0
0
0
0
585,374
588,687
593,242
628,329
640,104
646,615
655,143
664,700
675,118
685,716
694,038
0
0
00694,038685,716675,118664,700655,143646,615640,104628,329593,242588,687585,3740000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
411,277
0
434,011
582,535
585,374
588,687
593,242
628,329
640,104
646,615
655,143
664,700
675,118
685,716
694,038
651,731
610,266
610,266651,731694,038685,716675,118664,700655,143646,615640,104628,329593,242588,687585,374582,535434,0110411,277000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue582,022
Cost of Revenue-121,236
Gross Profit460,786460,786
 
Operating Income (+$)
Gross Profit460,786
Operating Expense-268,756
Operating Income192,030192,030
 
Operating Expense (+$)
Research Development76,063
Selling General Administrative95,289
Selling And Marketing Expenses97,404
Operating Expense268,756268,756
 
Net Interest Income (+$)
Interest Income14,730
Interest Expense-23,757
Other Finance Cost-2,883
Net Interest Income-11,910
 
Pretax Income (+$)
Operating Income192,030
Net Interest Income-11,910
Other Non-Operating Income Expenses0
Income Before Tax (EBT)173,396201,637
EBIT - interestExpense = 183,162
173,396
152,610
Interest Expense23,757
Earnings Before Interest and Taxes (EBIT)206,919197,153
Earnings Before Interest and Taxes (EBITDA)231,278
 
After tax Income (+$)
Income Before Tax173,396
Tax Provision-27,055
Net Income From Continuing Ops150,755146,341
Net Income128,853
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses389,992
Total Other Income/Expenses Net-9,60711,910
 

Technical Analysis of Harmony Biosciences Holdings
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Harmony Biosciences Holdings. The general trend of Harmony Biosciences Holdings is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Harmony Biosciences Holdings's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Harmony Biosciences Holdings.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 29.35 < 31.40 < 34.08.

The bearish price targets are: 28.63 > 26.34 > 22.89.

Tweet this
Harmony Biosciences Holdings Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Harmony Biosciences Holdings. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Harmony Biosciences Holdings Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Harmony Biosciences Holdings. The current macd is -0.78342389.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Harmony Biosciences Holdings price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Harmony Biosciences Holdings. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Harmony Biosciences Holdings price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Harmony Biosciences Holdings Daily Moving Average Convergence/Divergence (MACD) ChartHarmony Biosciences Holdings Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Harmony Biosciences Holdings. The current adx is 16.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Harmony Biosciences Holdings shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Harmony Biosciences Holdings Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Harmony Biosciences Holdings. The current sar is 32.00.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Harmony Biosciences Holdings Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Harmony Biosciences Holdings. The current rsi is 40.43. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Harmony Biosciences Holdings Daily Relative Strength Index (RSI) ChartHarmony Biosciences Holdings Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Harmony Biosciences Holdings. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Harmony Biosciences Holdings price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Harmony Biosciences Holdings Daily Stochastic Oscillator ChartHarmony Biosciences Holdings Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Harmony Biosciences Holdings. The current cci is -98.39384388.

Harmony Biosciences Holdings Daily Commodity Channel Index (CCI) ChartHarmony Biosciences Holdings Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Harmony Biosciences Holdings. The current cmo is -22.63976442.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Harmony Biosciences Holdings Daily Chande Momentum Oscillator (CMO) ChartHarmony Biosciences Holdings Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Harmony Biosciences Holdings. The current willr is -75.76687117.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Harmony Biosciences Holdings is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Harmony Biosciences Holdings Daily Williams %R ChartHarmony Biosciences Holdings Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Harmony Biosciences Holdings.

Harmony Biosciences Holdings Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Harmony Biosciences Holdings. The current atr is 1.29656924.

Harmony Biosciences Holdings Daily Average True Range (ATR) ChartHarmony Biosciences Holdings Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Harmony Biosciences Holdings. The current obv is -28,567,575.

Harmony Biosciences Holdings Daily On-Balance Volume (OBV) ChartHarmony Biosciences Holdings Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Harmony Biosciences Holdings. The current mfi is 31.55.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Harmony Biosciences Holdings Daily Money Flow Index (MFI) ChartHarmony Biosciences Holdings Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Harmony Biosciences Holdings.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Harmony Biosciences Holdings Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Harmony Biosciences Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.435
Ma 20Greater thanMa 5030.349
Ma 50Greater thanMa 10031.492
Ma 100Greater thanMa 20031.771
OpenGreater thanClose28.880
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Harmony Biosciences Holdings with someone you think should read this too:
  • Are you bullish or bearish on Harmony Biosciences Holdings? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Harmony Biosciences Holdings? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Harmony Biosciences Holdings

I send you an email if I find something interesting about Harmony Biosciences Holdings.


Comments

How you think about this?

Leave a comment

Stay informed about Harmony Biosciences Holdings.

Receive notifications about Harmony Biosciences Holdings in your mailbox!